We engage with a range of genomic studies and cohorts from the UK and beyond to pool together resources, expertise and capabilities from all our partners and collaborators. 

Key studies such us the Born in Bradford cohort, TwinsUK, the PROMIS study, UK Biobank, FinnGen are just a few examples of how cohorts can support understanding of therapeutic and disease mechanisms and provide insights into therapeutic potential and the limitations of emerging therapies.

UCL based cohorts can be found here